Boston Scientific Adds ‘Novel’ Technology Via This Acquisition For Interventional Oncology
Boston Scientific Corporation (NYSE:BSX) has acquired privately-held Obsidio Inc that developed the Gel Embolic Material (GEM) technology to embolize blood vessels in the…